Results 11 to 20 of about 623,160 (229)

Unveiling the Features of Mercury-Associated Minimal Change Disease: Comparison with Primary Minimal Change Disease [PDF]

Kidney Diseases, 2020
<b><i>Introduction:</i></b> Long-term exposure to mercury can cause minimal change disease. However, the current understanding of mercury-associated minimal change disease (M-MCD) is inadequate. To improve the understanding of M-MCD, this study retrospectively analyzed the clinicopathological, ultrastructural, and prognostic ...
Ai-bo Qin, Xiao-juan Yu, Su-xia Wang, Fu-de Zhou, Ming-hui Zhao   +4 more
openaire   +4 more sources

Association between anti-nephrin autoantibodies and disease activity in minimal change disease. [PDF]

Ann Med
Background Minimal change disease (MCD) is a podocytopathy linked to immune-mediated mechanisms, with emerging evidence suggesting the presence of anti-nephrin autoantibodies in a subset of patients.
Guo M, Yan L, Zhao J, Liu X, Zhang H, Li M, Zhang K, Cui J, Wang Y, Chen X, Dong Z, Li Q.   +11 more
europepmc   +2 more sources

Minimal change disease in horseshoe kidney

Pan African Medical Journal, 2017
The horseshoe kidney is a frequent urological birth defect. The most frequent complications are urinary tract infections, stones and hydronephrosis. The occurrence of glomerular disease in horseshoe kidney is rare. Therefore, we report the first case of minimal change disease occurring in a patient with horseshoe kidney in literature.
Yosr Chaabouni, Rahma Guesmi, Yosr Hentati, Khaoula Kammoun, Mohamed Ben Hmida, Zeineb Mnif, Tahya Boudawara, Jamil Hachicha   +7 more
openaire   +3 more sources

A membranous nephropathy variant mimicking minimal change disease. [PDF]

J Pathol Clin Res
This study characterizes a novel disease pattern of membranous nephropathy (MN) that exhibits overlapping clinicopathological features with minimal change disease (MCD), termed ‘MCD‐like MN’.
Pan C, Xiang S, Jiang M, Li Y, Huang B, Ye T, Du Y, Tang X, Yuan Y.   +8 more
europepmc   +2 more sources

Diabetic nephropathy with minimal change disease: a case report. [PDF]

Front Endocrinol (Lausanne)
BackgroundType 2 diabetes mellitus (T2DM) has become the main cause of end stage renal disease (ESRD) in the past decade. Diabetic kidney disease (DKD) is one of the most serious complications of diabetes.
Miao P, Mo X, Zhang X, Zhang M.
europepmc   +2 more sources

Telitacicept for minimal change disease

The Kaohsiung Journal of Medical Sciences, 2023
Shan Li, Lin Ding, Yan‐Jiang Yang, Xiang‐Dong Yang   +3 more
openaire   +3 more sources

Minimal Change Disease in an Adult: A Case Report

Journal of Nepal Medical Association, 2022
Minimal change disease is an important cause of nephrotic syndrome in children, however, few cases are seen among adults. There is very little literature regarding the occurrence of minimal change disease in adults. We reported a case of a 63-year-old male who presented with the complaint of swelling around the eyes mostly during the morning for 18 ...
Shashank Neupane, Prasamsa Pudasaini, Anupam Sharma, Shriya Sharma, Aakriti Adhikari, Kumar Roka   +5 more
openaire   +4 more sources

Rituximab in Minimal Change Disease

Canadian Journal of Kidney Health and Disease, 2017
Treatment with rituximab, a monoclonal antibody against the B-lymphocyte surface protein CD20, leads to the depletion of B cells. Recently, rituximab was reported to effectively prevent relapses of glucocorticoid-dependent or frequently relapsing minimal change disease (MCD).
Nima Madanchi, Martin Bitzan, Tomoko Takano   +2 more
openaire   +2 more sources

Obinutuzumab alone may be an effective option for adult minimal change disease: a single-center retrospective observational study. [PDF]

BMC Nephrol
Background Obinutuzumab is a novel glycoengineered type II anti-CD20 monoclonal antibody with more potent and sustained B-cell depletion than rituximab.
Bai Q, Tao LY, Zheng D, Wang Y.
europepmc   +2 more sources

Kartagener syndrome with minimal change disease: a case report. [PDF]

J Med Case Rep
Background Kartagener syndrome is characterized by chronic sinusitis, bronchiectasis, and total visceral transposition. While there are few reports of Kartagener syndrome combined with kidney disease, there are none that specifically report Kartagener ...
Huang Q, Luan J, Zhou H.
europepmc   +2 more sources